Search - tctmd.com

Displaying 121 - 140 of 152

Sort: Relevancy | Date

Presentation TCT 2015

Risk of Paradoxical Embolism With Pacemaker Leads

Presenter: John D. Carroll, Mark Reisman, Samir R. Kapadia

October 14, 2015

News Conference News TCT 2015

Updates to CoreValve Extreme Risk Study Encouraging

October 13, 2015

News Conference News TCT 2015

Robotic Systems to Play Greater Role in Cath Lab of the Future

Todd Neale

October 12, 2015

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

News Conference News TCT 2015

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

Presentation TCT 2015

How to Prevent Annular Rupture, Coronary Occlusion, and Permanent Pacemakers

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Oscar A. Mendiz

October 11, 2015

Presentation TCT 2015

Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Presenter: Marian C. Hawkey, Ganesh Manoharan

October 11, 2015

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

Presentation TCT 2014

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Malek Al-Hawwas, MD

September 16, 2014

Presentation TCT 2014

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Tamim Nazif

September 14, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

News Conference News TCT 2014

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

September 13, 2014

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

News Conference News TCT 2013

Second-Generation TAVR Device Overcomes Issues of Current Valves

October 31, 2013

News Conference News TCT 2013

VA Medical Centers’ CART Program Improves Patient Care, Longitudinal Research

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

Presenter: Nicolas Dumonteil

October 29, 2013

Presentation TCT 2013

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

Presenter: Tamim Nazif

October 29, 2013

Presentation TCT 2013

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on "When to Treat"

Presenter: Karl-Heinz Kuck

October 28, 2013

Advertisement

Risk of Paradoxical Embolism With Pacemaker Leads

Updates to CoreValve Extreme Risk Study Encouraging

Robotic Systems to Play Greater Role in Cath Lab of the Future

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

How to Prevent Annular Rupture, Coronary Occlusion, and Permanent Pacemakers

Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Global TAVR Market Poised to Exceed DES Market by 2025

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Conduction Disturbances (New LBBB and Pacemakers) After TAVR: Frequency, Clinical Impact, and Management Considerations

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

TAVR a Viable Option for Intermediate-Risk Patients

Second-Generation TAVR Device Overcomes Issues of Current Valves

VA Medical Centers’ CART Program Improves Patient Care, Longitudinal Research

Innovation in Intervention: Perspectives from Industry

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on "When to Treat"

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content